Ultragenyx Pharmaceutical Inc. (RARE) Forms $45.59 Double Bottom; Mariner Wealth Advisors Upped Its Amazon Com (AMZN) Position

Ultragenyx Pharmaceutical Inc. (RARE) formed double bottom with $44.22 target or 3.00% below today’s $45.59 share price. Ultragenyx Pharmaceutical Inc. (RARE) has $2.14 billion valuation. The stock decreased 5.38% or $2.59 during the last trading session, reaching $45.59. About 594,794 shares traded or 2.63% up from the average. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has declined 6.49% since February 21, 2017 and is downtrending. It has underperformed by 23.19% the S&P500.

Mariner Wealth Advisors Llc increased Amazon Com Inc (AMZN) stake by 8.02% reported in 2017Q3 SEC filing. Mariner Wealth Advisors Llc acquired 930 shares as Amazon Com Inc (AMZN)’s stock rose 13.58%. The Mariner Wealth Advisors Llc holds 12,529 shares with $12.05 million value, up from 11,599 last quarter. Amazon Com Inc now has $722.47B valuation. The stock increased 1.64% or $24.02 during the last trading session, reaching $1492.37. About 2.19M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 37.41% since February 21, 2017 and is uptrending. It has outperformed by 20.71% the S&P500.

Since December 7, 2017, it had 0 buys, and 1 sale for $3.25 million activity. WILKE JEFFREY A sold $3.25M worth of Amazon.com, Inc. (NASDAQ:AMZN) on Thursday, December 7.

Among 53 analysts covering Amazon.com (NASDAQ:AMZN), 50 have Buy rating, 0 Sell and 3 Hold. Therefore 94% are positive. Amazon.com had 273 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, February 2, the company rating was maintained by UBS. As per Wednesday, December 9, the company rating was maintained by Nomura. The company was maintained on Wednesday, May 31 by Jefferies. The firm has “Buy” rating given on Tuesday, November 1 by Axiom Capital. Piper Jaffray reinitiated the shares of AMZN in report on Tuesday, January 3 with “Overweight” rating. Loop Capital maintained it with “Buy” rating and $1500 target in Tuesday, January 23 report. The stock has “Buy” rating by Oppenheimer on Friday, July 28. The firm has “Buy” rating by Jefferies given on Friday, October 27. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Aegis Capital on Friday, February 2. The company was upgraded on Thursday, September 22 by Argus Research.

Mariner Wealth Advisors Llc decreased Vanguard Index Fds (VOO) stake by 2,191 shares to 6,557 valued at $1.51M in 2017Q3. It also reduced Cboe Hldgs Inc (NASDAQ:CBOE) stake by 11,000 shares and now owns 55,544 shares. Alps Etf Tr (AMLP) was reduced too.

Investors sentiment decreased to 1.26 in 2017 Q3. Its down 0.10, from 1.36 in 2017Q2. It turned negative, as 73 investors sold AMZN shares while 549 reduced holdings. 127 funds opened positions while 657 raised stakes. 279.77 million shares or 1.91% less from 285.20 million shares in 2017Q2 were reported. Tanaka Capital Mgmt holds 0.29% or 135 shares in its portfolio. Wisconsin-based Madison Invest has invested 0.05% in Amazon.com, Inc. (NASDAQ:AMZN). Us Financial Bank De reported 241,330 shares. Pinnacle Associate reported 0.12% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Kelly Lawrence W & Ca invested in 0.02% or 127 shares. Nichols Pratt Advisers Limited Liability Partnership Ma reported 2,516 shares. Cornerstone Holdings Limited Liability Company reported 193,954 shares. Oarsman Cap Inc stated it has 418 shares. Highland Capital Mngmt Lp owns 7,500 shares. Asset Advsr owns 5,995 shares for 1.03% of their portfolio. Barclays Plc owns 680,800 shares. Conatus Lp accumulated 14,813 shares. Rafferty Asset Mngmt Limited holds 0.04% in Amazon.com, Inc. (NASDAQ:AMZN) or 2,038 shares. Dorsal Cap Management Ltd Com stated it has 85,000 shares or 4.25% of all its holdings. Wealthcare Ltd Company accumulated 0.01% or 53 shares.

Investors sentiment decreased to 1.19 in 2017 Q3. Its down 0.65, from 1.84 in 2017Q2. It worsened, as 17 investors sold Ultragenyx Pharmaceutical Inc. shares while 40 reduced holdings. 15 funds opened positions while 53 raised stakes. 39.75 million shares or 1.85% less from 40.50 million shares in 2017Q2 were reported. Alps Advsr Inc owns 41,814 shares for 0.02% of their portfolio. Perigon Wealth Mgmt Llc accumulated 100 shares. Royal State Bank Of Canada reported 0.01% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Sg Americas Secs Limited Liability accumulated 0% or 2,929 shares. Raymond James & Assocs has 0% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Gam Ag holds 0.18% or 78,100 shares. Alliancebernstein Lp has 644,300 shares for 0.03% of their portfolio. Eventide Asset Mgmt Ltd Limited Liability Company owns 0.26% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for 87,400 shares. New York State Common Retirement Fund holds 0% or 70,036 shares in its portfolio. Qs Investors Limited Liability Co holds 0% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) or 907 shares. Parametric Assoc Ltd Llc has invested 0% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Blackrock invested in 3.76M shares. Metropolitan Life Insurance Co invested in 0.01% or 26,473 shares. Fmr Lc holds 3.66 million shares or 0.02% of its portfolio. California State Teachers Retirement reported 0.01% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: